Methylprednisolone in acute spinal cord injury: fact or fantasy?
Walker
J
J
Oregon Health Sciences University, Portland, OR, USA.
Criddle
L M
LM
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002574:Cervical Vertebrae / Q000293:injuries*; D004638:Emergency Treatment / Q000379:methods* / Q000592:standards; D019317:Evidence-Based Medicine; D005538:Football / Q000293:injuries*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D018579:Patient Selection; D011782:Quadriplegia / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D013119:Spinal Cord Injuries / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D016103:Spinal Fractures / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D018696:Neuroprotective Agents; D008775:Methylprednisolone